@article{Burn_E-2020_7087,
title = {Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study},
author = {Burn, E. and You, S. and Sena, A. and Kostka, K. and Abedtash, H. and Abrahão, M. and Alberga, A. and Alghoul, H. and Alser, O. and Alshammari, T. and Aragón, M. and Areia, C. and Banda, J. and Cho, J. and Culhane, A. and Davydov, A. and DeFalco, F. and Duarte-Salles, T. and DuVall, S. and Falconer, T. and Fernández-Bertolín, S. and Gao, W. and Golozar, A. and Hardin, J. and Hripcsak, G. and Huser, V. and Jeon, H. and Jing, Y. and Jung, C. and Kaas-Hansen, B. and Kaduk, D. and Kent, S. and Kim, Y. and Kolovos, S. and Lane, J. and Lee, H. and Lynch, K. and Makadia, R. and Matheny, M. and Mehta, P. and Morales, D. and Natarajan, K. and Nyberg, F. and Ostropolets, A. and Park, R. and Park, J. and Posada, J. and Prats-Uribe, A. and Rao, G. and Reich, C. and Rho, Y. and Rijnbeek, P. and Schilling, L. and Schuemie, M. and Shah, N. and Shoaibi, A. and Song, S. and Spotnitz, M. and Suchard, M. and Swerdel, J. and Vizcaya, D. and Volpe, S. and Wen, H. and Williams, A. and Yimer, B. and Zhang, L. and Zhuk, O. and Prieto-Alhambra, D. and Ryan, P.},
month = {dec},
year = {2020},
abstract = {Comorbid conditions appear to be common among individuals hospitalised with coronavirus disease 2019 (COVID-19) but estimates of prevalence vary and little is known about the prior medication use of patients. Here, we describe the characteristics of adults hospitalised with COVID-19 and compare them with influenza patients. We include 34,128 (US: 8362, South Korea: 7341, Spain: 18,425) COVID-19 patients, summarising between 4811 and 11,643 unique aggregate characteristics. COVID-19 patients have been majority male in the US and Spain, but predominantly female in South Korea. Age profiles vary across data sources. Compared to 84,585 individuals hospitalised with influenza in 2014-19, COVID-19 patients have more typically been male, younger, and with fewer comorbidities and lower medication use. While protecting groups vulnerable to influenza is likely a useful starting point in the response to COVID-19, strategies will likely need to be broadened to reflect the particular characteristics of individuals being hospitalised with COVID-19.},
volume = {11},
journal = {Nature Communications},
publisher = {Springer Nature},
url = {https://doi.org/10.1038/s41467-020-18849-z},
}
